Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-139x|28|4|404-412

ISSN： 0894-0959

Source： SEMINARS IN DIALYSIS, Vol.28, Iss.4, 2015-07, pp. : 404-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticancer Drugs in End‐Stage Kidney Disease Patients

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 413-416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Markers of Arterial Stiffness Are Risk Factors for Progression to End-Stage Renal Disease among Patients with Chronic Kidney Disease Stages 4 and 5

By  

Nephron Clin Pract, Vol. 107, Iss. 4, 2007-11 ,pp. : c177-c181

Karger

Access to resources Recommend Favorite

Outcomes of Stage 3–5 Chronic Kidney Disease before End-Stage Renal Disease at a Single Center in Taiwan

By  

Nephron Clin Pract, Vol. 109, Iss. 3, 2008-07 ,pp. : c109-c118

Karger

Access to resources Recommend Favorite

Prevalence of Chronic Kidney Disease and Associated Risk Factors, and Risk of End-Stage Renal Disease: Data from the PREVADIAB Study

By  

Nephron Clin Pract, Vol. 119, Iss. 1, 2011-06 ,pp. : c35-c40

Karger

Access to resources Recommend Favorite

Association of Depression with Markers of Nutrition and Inflammation in Chronic Kidney Disease and End-Stage Renal Disease

By  

Nephron Clin Pract, Vol. 102, Iss. 3-4, 2005-11 ,pp. : c115-c121

Karger

Access to resources Recommend Favorite